Finally, we consider the available evidence on the therapeutic potential of targeting TSLP signaling for the treatment of CRSwNP and discuss ongoing trials of promising therapeutic candidates. The gene discussed is TSLP; the disease is chronic rhinosinusitis with nasal polyps.